It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Promoter-proximal pausing of RNA polymerase II is a key process regulating gene expression. In latent HIV-1 cells, it prevents viral transcription and is essential for latency maintenance, while in acutely infected cells the viral factor Tat releases paused polymerase to induce viral expression. Pausing is fundamental for HIV-1, but how it contributes to bursting and stochastic viral reactivation is unclear. Here, we performed single molecule imaging of HIV-1 transcription. We developed a quantitative analysis method that manages multiple time scales from seconds to days and that rapidly fits many models of promoter dynamics. We found that RNA polymerases enter a long-lived pause at latent HIV-1 promoters (>20 minutes), thereby effectively limiting viral transcription. Surprisingly and in contrast to current models, pausing appears stochastic and not obligatory, with only a small fraction of the polymerases undergoing long-lived pausing in absence of Tat. One consequence of stochastic pausing is that HIV-1 transcription occurs in bursts in latent cells, thereby facilitating latency exit and providing a rationale for the stochasticity of viral rebounds.
The ability of HIV to alternate between acute and latent forms is thought to rely on a transcriptional feedback loop where polymerase pausing is released by the viral protein Tat. Here, the authors show that viral genome transcription can occur in a burst-like stochastic manner in the absence of Tat.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France (GRID:grid.429192.5) (ISNI:0000 0004 0599 0285); Equipe labélisée Ligue Nationale Contre le Cancer, University of Montpellier, CNRS, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141)
2 Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France (GRID:grid.429192.5) (ISNI:0000 0004 0599 0285)
3 Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France (GRID:grid.429192.5) (ISNI:0000 0004 0599 0285); Equipe labélisée Ligue Nationale Contre le Cancer, University of Montpellier, CNRS, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141); Institut de Génétique Humaine, University of Montpellier, CNRS, Montpellier, France (GRID:grid.462268.c) (ISNI:0000 0000 9886 5504)
4 LPHI, UMR CNRS 5235, University of Montpellier, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141)
5 Equipe labélisée Ligue Nationale Contre le Cancer, University of Montpellier, CNRS, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141); Institut de Génétique Humaine, University of Montpellier, CNRS, Montpellier, France (GRID:grid.462268.c) (ISNI:0000 0000 9886 5504); LPHI, UMR CNRS 5235, University of Montpellier, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141)
6 Equipe labélisée Ligue Nationale Contre le Cancer, University of Montpellier, CNRS, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141); Institut de Génétique Humaine, University of Montpellier, CNRS, Montpellier, France (GRID:grid.462268.c) (ISNI:0000 0000 9886 5504)
7 Unité Imagerie et Modélisation, Institut Pasteur and CNRS UMR 3691, Paris, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282)
8 Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France (GRID:grid.429192.5) (ISNI:0000 0004 0599 0285); Equipe labélisée Ligue Nationale Contre le Cancer, University of Montpellier, CNRS, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141); Microbiology Fundamental and Pathogenicity CNRS UMR 5234, University of Bordeaux, Bordeaux, France (GRID:grid.412041.2) (ISNI:0000 0001 2106 639X)